Enanta's HCV Collaboration Partner AbbVie Receives Approval By European Commission For MAVIRET To Shorten Treatment Duration To Eight Weeks For Treatment-Naïve HCV Patients With Compensated Cirrhosis
Benzinga Newsdesk